A Study to Evaluate Efficacy and Safety Profile of Zabofloxacin Tablet 400mg and Moxifloxacin Tablet 400mg
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to Evaluate the Efficacy and Safety Profiles of oral multiple
dose of Zabofloxacin Tablet 400 mg.
Phase:
Phase 3
Details
Lead Sponsor:
Dong Wha Pharmaceutical Co. Ltd.
Collaborators:
Ajou University Asan Medical Center Bundang CHA Hospital Catholic University of Korea Saint Paul's Hospital Chonbuk National University Hospital Chonnam National University Hospital Chosun University Hospital Chungbuk National University Chungnam National University Hospital DongGuk University Ewha Womans University Mokdong Hospital Gachon University Gil Medical Center Gyeongsang National University Hospital Hallym University Medical Center Hanyang University Incheon St.Mary's Hospital Inje University Kangdong Sacred Heart Hospital KangWon National University Hospital Keimyung University Dongsan Medical Center Konkuk University Medical Center Konyang University Hospital Korea University Anam Hospital Kyunghee University Medical Center Masan Samsung Hospital, South Korea Severance Hospital The Catholic University of Korea Ulsan University Hospital Wonju Severance Christian Hospital Yeungnam University Yeungnam University Hospital
Treatments:
Fluoroquinolones Moxifloxacin Norgestimate, ethinyl estradiol drug combination